• SENSEX 82,164.70
    -335.77 (--0.41%)
  • BANKNIFTY 56,754.70
    -201.30 (--0.35%)
  • ICICI Bank
    1,416.90 1,153.30(%)
  • Reliance Industr
    1,487.80 1,115.55(%)
  • Infosys
    1,567.45 1,307.10(%)
  • JP Power Ven.
    24.75 24.86(%)
  • M & M
    3,102.95 3,276.30(%)
  • Hind. Unilever
    2,492.60 2,136.00(%)
  • Enviro Infra
    288.50 392.00(%)
  • Eternal Ltd
    267.75 304.50(%)
  • Power Grid Corpn
    300.50 366.20(%)
  • Kotak Mah. Bank
    2,204.65 1,679.10(%)
  • Titan Company
    3,376.05 3,866.15(%)
  • Hind.Aeronautics
    4,903.40 5,580.00(%)
  • Neuland Labs.
    13,673.80 18,089.55(%)
  • Garden Reach Sh.
    2,644.85 1,180.10(%)
  • Suzlon Energy
    66.45 86.04(%)
  • Adani Power
    619.30 752.15(%)
  • ITC
    419.30 500.01(%)
  • Avenue Super.
    3,928.85 3,337.10(%)
  • Ola Electric
    43.60 157.53(%)
  • Crizac
    321.90 275.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kabra Drugs Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 2908.0
  • ISIN : INE323K01017
19.75 -1 (-4.96%)
  • As on 14 Jul 2025 (EOD)

  • Today’s Low

    19.75

  • Today’s High

    19.75

  • Open

    19.75

  • Perv Close

    20.78

  • 52W Low

    8.30

  • 52W High

    22.77

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    46.82

  • Div & Yield %

    0.00

  • Book Value(₹)

    10.40

  • Debt-Equity Ratio

    -4.96

  • AGM Date

    11-Jul-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    46.82

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    23.71

  • BV (₹)

    10.40

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -1.09

  • NP Var(%)

    -47.0

  • Div%

    0.0

  • CPS (₹)

    -0.50

  • EPS (₹)

    -0.50

  • Traded Value (₹ in Lakhs)

    46.82

  • 52 Week High

    22.77

  • 52 Week Low

    8.30

  • Price BSE

    20.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    46.82

  • P/C Ratio

    -44.00

  • P/E Ratio

    -43.70

  • Price Vs.BV

    -0.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.00 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.01 0.00 0.00 0.02 0.01
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 0.00 0.01 0.00 0.00 0.02 0.01
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.40 0.23 0.09 0.05 0.00 0.03
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Selling and Administration Expenses 0.30 0.09 0.08 0.10 0.05 0.10
Miscellaneous Expenses 0.04 0.02 0.01 0.00 0.00 0.00
Employee Benefit Expenses 0.40 0.23 0.09 0.05 0.00 0.03
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 0.74 0.34 0.18 0.15 0.05 0.14
Operating Profit -0.74 -0.34 -0.18 -0.15 -0.03 -0.12
Interest 0.00 0.00 0.00 0.00 0.00 0.01
Gross Profit -0.74 -0.34 -0.18 -0.15 -0.03 -0.13
Depreciation 0.00 0.00 0.01 0.03 0.03 0.03
Profit Before Tax -0.74 -0.34 -0.19 -0.18 -0.06 -0.16
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -0.74 -0.34 -0.19 -0.18 -0.06 -0.16
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -0.74 -0.34 -0.19 -0.18 -0.06 -0.16
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -5.12 -4.78 -4.60 -4.42 -4.36 -4.19
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -5.86 -5.12 -4.78 -4.60 -4.42 -4.36
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -1.68 -0.77 -0.42 -0.41 -0.14 0.00
Earnings Per Share(Adj)-Unit Curr -1.68 -0.77 -0.42 - -0.14 0.00
Book Value -3.34 -1.67 -0.90 -0.47 -0.06 0.07
Book Value(Adj)-Unit Curr -3.34 -1.67 -0.90 - -0.06 0.07

Shareholding Pattern

  • Public Share Holding

    100.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 283,143 1.19 195,643 34
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 8,600 0.04 8,600 6
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 617,984 2.61 617,784 51
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 20,166,910 85.06 20,141,710 179
Individuals holding nominal share capital up to Rs. 1 lakh 2,578,939 10.88 1,247,438 7,163
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 23,707,850 100.00 22,263,449 7,435
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 23,707,850 100.00 22,263,449 7,435

Company Background

Kabra Drugs LtdPharmaceuticals - Indian - Formulations

  • Kabra Drugs Ltd
  • BSE Code : 2908.0
  • ISIN : INE323K01017

  • Incorporation Year

    1989

  • Registered Office

    270 Shastri Market Indore
    , Indore,
    Madhya Pradesh-452007

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    N Aravind

  • Company Secretary

    Monika Sanwal

  • Auditor

    Rishi Sekhri & Associates/PPN and Company

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Ankit Consultancy Pvt Ltd
    Plot No. 60,
    Electronic Complex,Pardeshipura
    Mumbai - Indore - 452010

Kabra Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kabra Drugs 19.75 0.00 0.00 -42.93 0.00
Abbott India 34,409.95 6,097.18 5,848.91 51.70 44.71
Astrazeneca Phar 9,237.05 1,330.33 1,295.53 199.50 33.26
P & G Health Ltd 5,777.05 1,166.89 1,151.26 38.18 39.76
Glaxosmi. Pharma 3,242.30 3,866.05 3,723.49 59.77 58.72
Cipla 1,485.05 20,029.57 19,044.85 23.25 21.40
Amrutanjan Healt 726.25 437.58 421.23 41.31 20.84
Fermenta Biotec. 384.45 315.24 307.09 16.74 4.10
Guj. Themis Bio. 343.55 174.19 169.82 76.69 44.82
Bliss GVS Pharma 153.75 703.42 667.20 23.51 9.16
Ambalal Sarabhai 36.16 19.33 4.04 33.48 2.10